Jane Street Group, LLC Reata Pharmaceuticals Inc Call Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$24.12 - $39.6 $569,232 - $934,560	23,600 Added 60.2%	62,800 $2.06 Million
Q4 2021 Feb 15, 2022	SELL	$25.61 - $110.96 $542,932 - $2.35 Million	-21,200 Reduced 35.1%	39,200 $1.03 Million
Q3 2021 Nov 16, 2021	BUY	$100.0 - $143.02 $1.89 Million - $2.7 Million	18,900 Added 45.54%	60,400 $6.08 Million
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $508,755 - $983,385	6,500 Added 18.57%	41,500 $5.87 Million
Q1 2021 May 18, 2021	BUY	$94.25 - $132.81 $414,700 - $584,364	4,400 Added 14.38%	35,000 $3.49 Million
Q4 2020 Feb 17, 2021	SELL	$102.03 - $184.62 $499,947 - $904,638	-4,900 Reduced 13.8%	30,600 $3.78 Million
Q3 2020 Nov 17, 2020	BUY	$93.53 - $163.34 $897,888 - $1.57 Million	9,600 Added 37.07%	35,500 $3.46 Million
Q2 2020 Aug 17, 2020	BUY	$126.3 - $176.56 $2.12 Million - $2.97 Million	16,800 Added 184.62%	25,900 $4.04 Million
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $1.13 Million - $2.25 Million	9,100 New	9,100 $1.31 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.